Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
Moreira, Thais G, Matos, Kimble T F, De Paula, Giovana S, Santana, Thais M M, Da Mata, Raquel G, Pansera, Fernando C, Cortina, Andre S, Spinola, Marcelle G, Baecher-Allan, Clare M, Keppeke, Gerson D, Jacob, Jules, Palejwala, Vaseem, Chen, Karen, Izzy, Saef, Healey, Brian C, Rezende, Rafael M, Dedivitis, Rogerio A, Shailubhai, Kunwar, Weiner, Howard L
Published in Frontiers in immunology (12.08.2021)
Published in Frontiers in immunology (12.08.2021)
Get full text
Journal Article
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
Moreira, Thais G, Matos, Kimble T F, De Paula, Giovana S, Santana, Thais M M, Da Mata, Raquel G, Pansera, Fernando C, Cortina, Andre S, Spinola, Marcelle G, Baecher-Allan, Clare M, Keppeke, Gerson D, Jacob, Jules, Palejwala, Vaseem, Chen, Karen, Izzy, Saef, Healey, Brian C, Rezende, Rafael M, Dedivitis, Rogerio A, Shailubhai, Kunwar, Weiner, Howard L
Published in Frontiers in immunology (12.01.2022)
Published in Frontiers in immunology (12.01.2022)
Get full text
Journal Article